The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

PLoS ONE

Topics

Medicine

Cancer Oncology

Immunology

Internal Medicine

Molecular Biology

Show all topics

DOI

10.1371/journal.pone.0053745

License

CC-BY

Other Formats

PDF